Filing Details
- Accession Number:
- 0001209191-22-016504
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-03-04 20:04:58
- Reporting Period:
- 2022-03-02
- Accepted Time:
- 2022-03-04 20:04:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1029142 | Dynavax Technologies Corp | DVAX | Pharmaceutical Preparations (2834) | 330728374 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1580849 | Robert Janssen | C/O Dynavax Technologies 2100 Powell Street, Suite 900 Emeryville CA 94608 | Senior Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-02-15 | 467 | $10.29 | 38,743 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2022-03-02 | 10,000 | $0.00 | 48,743 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-03-03 | 6,276 | $10.56 | 42,467 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-03-03 | 17,760 | $10.57 | 24,707 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Unit | Acquisiton | 2022-03-02 | 10,000 | $0.00 | 10,000 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 20,000 | No | 4 | M | Direct |
Footnotes
- Includes 467 shares acquired under issuer's 2014 Employee Stock Purchase Plan (ESPP) on February 15, 2022.
- Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annualanniversary of February 3, 2021.
- The reporting person is reporting the sale of 6276 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the delivery of common stock to the reporting person on March 2, 2022.
- The reporting person is reporting the sale of 17,760 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the delivery of common stock to the reporting person on March 2, 2022. The conversion of the RSUs into common stock was reported on the reporting person's Form 4 on February 14, 2022.
Billionaire Hedge Funds
